Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 12,430,000 | 10,550,000 | 8,356,000 | 5,523,000 | 4,015,700 |
| Cost of Goods | 2,082,000 | 1,731,000 | 1,341,000 | 736,000 | 443,000 |
| Gross Profit | 10,348,000 | 8,819,000 | 7,015,000 | 4,787,000 | 3,572,700 |
| Operating Expenses | 5,500,000 | 5,471,000 | 3,924,000 | 5,572,000 | 2,041,500 |
| Operating Income | 4,848,000 | 3,348,000 | 3,091,000 | -785,000 | 1,531,200 |
| Interest Expense | 99,000 | 38,000 | 31,000 | 44,000 | 13,600 |
| Other Income | 119,000 | 85,000 | 113,000 | 144,000 | 168,700 |
| Pre-tax Income | 4,868,000 | 3,395,000 | 3,173,000 | -685,000 | 1,686,300 |
| Income Tax | 1,194,000 | 1,032,000 | 914,000 | 707,000 | 566,600 |
| Net Income Continuous | 3,674,000 | 2,363,000 | 2,259,000 | -1,392,000 | 1,119,700 |
| Net Income | $3,674,000 | $2,363,000 | $2,259,000 | $-1,392,000 | $1,119,700 |
| EPS Basic Total Ops | 2.97 | 1.86 | 1.75 | -1.21 | 1.07 |
| EPS Basic Continuous Ops | 2.97 | 1.86 | 1.75 | -1.21 | 1.07 |
| EPS Diluted Total Ops | 2.93 | 1.81 | 1.69 | -1.21 | 1.03 |
| EPS Diluted Continuous Ops | 2.92 | 1.79 | 1.68 | -1.21 | 1.03 |
| EBITDA(a) | $5,689,000 | $4,082,000 | $3,778,000 | $-338,000 | $1,797,100 |